CICLOPIROX 3%- ciclopirox 3% gel 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CICLOPIROX 3%

Directions for use

sdf

Sincerus Florida, LLC. Adverse reactions

sd

Active, inactive

as

NDC 72934- 1042-2 CICLOPIROX OLAMINE USP 3%. Gel 30 gm

zc

CICLOPIROX 3% 
ciclopirox 3% gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1042
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CICLOPIROX OLAMINE (UNII: 50MD4SB4AP) (CICLOPIROX - UNII:19W019ZDRJ) CICLOPIROX3 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-1042-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/20/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/20/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-1042)

Revised: 5/2019
Document Id: 89574010-4281-0d72-e053-2995a90a5295
Set id: 89574010-4280-0d72-e053-2995a90a5295
Version: 1
Effective Time: 20190520
 
Sincerus Florida, LLC